Medinice PacePress photo

PacePressSmart pressure
Confident recovery

About the product

PacePress is an innovative electronic compression band designed to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators (ICDs). It helps prevent postoperative internal bleeding, a serious complication to patients that also increases treatment costs. The device is simple to use, does not need any adjustments, and once explained in the hospital, patients can easily continue using it on their own at home.

Product video

The Problem

Approximately 1.5 million Cardiac Implantable Electronic Device (CIED) procedures are performed globally each year, including 50,000 in Poland

About 60% of patients undergoing CIED implantation are at risk of developing postoperative complications such as:

  • hematoma
  • infection
  • need for reoperation

Current postoperative care standards do not eliminate the risk of complications

These standards typically include:

  • immobilization of the patient in a lying position for at least one day
  • applying pressure to the implantation site using sandbags or weighting it with cold compresses
PacePress schema

Current prevention does not guarantee the absence of complications

FOR THE PATIENT

  • standard prophylaxis is associated with patient discomfort, including immobilization and pain during even the simplest activities
  • postoperative complications may be associated with discomfort and additional interventions
  • the management of complications prolongs the patient's hospital stay

FOR THE HOSPITAL

  • the patient requires continuous nursing supervision following surgery
  • postoperative complications such as hematomas typically occur during the patient's hospital stay
  • the management of complications post implantation increases hospital costs and occupies necessary beds

The Solution

PacePress provides faster recovery after CIED implantations

PacePress is a medical device designed to minimize the risk of complications and reoperations, providing comfort to the patient.

An innovative compression band through automatic compression of the CIED implantation site reduces the risk of postoperative hematomas.

PacePress schema

Patented design and functionalities

Key elements of PacePress are the cuff and the pumping unit.

The ergonomic harness allows for the adjustment of the cuff to the individual needs and anatomy of the patient.

The pumping unit is housed in a lightweight and portable casing. The device features pressure regulation, controlled via an easy-to-use touchscreen panel.

PacePress schema

Risk groups

PacePress is recommended for several risk groups, which together make up approximately 60% of all patients. These include individuals:

  • taking anticoagulant or antiplatelet medications (49%)
  • older adults – simple design helps ensure proper use after brief guidance
  • with comorbidities such as diabetes, heart failure, kidney failure, or a BMI below 23 kg/m²
  • undergoing revision or reconstruction surgery (29%)
  • facing a long or complex procedure, or undergoing reoperation within three months
PacePress user risk groups

Global Patent Protection

Our PacePress technology is protected by a robust portfolio of international patents, underscoring our commitment to innovation and global leadership. With patents granted in major markets - including the US, Canada, China, Japan, South Korea, and Europe, as well as international coverage under WIPO - PacePress is safeguarded by a comprehensive and far-reaching intellectual property strategy. This broad protection ensures the uniqueness, reliability, and competitive advantage of our technology worldwide.

PacePress patents

PacePress key features

  • Reduces the risk of hematoma and infection in the postoperative cavity
  • Supports adherence to local compression guidelines in the early period after CIED implantation
  • LED indicators facilitate the control of compression time after the procedure
PacePress summary
  • Potential reduction in hospital stay
  • Allows for continued compression for up to four days in home conditions
  • Increases control, safety, comfort, and mobility of the patient
PacePress summary
More about our innovations

We Care About Your Privacy

Medinice S.A. uses cookies to improve and customize users experience on our website. By selecting 'Accept', you consent to the use of all cookies that gather and use information about your interactions with our site to provide personalized content and enhance your digital experience. Please read our Privacy Policy for more information.

Contact

Address

Hankiewicza 2

02-103 Warszawa

Poland

Follow us

NIP: 6631868308

REGON: 260637552

KRS: 0000443282

EU logos
EU logos
EU logos